Literature DB >> 10800768

Genetic aspects of central hypothyroidism.

R Collu1.   

Abstract

Central hypothyroidism, characterized by insufficient TSH secretion in the presence of low levels of thyroid hormones, is a rare disorder. It has recently been found that, although mainly due to tumors or infiltrative diseases of the hypothalamo-pituitary area or to pituitary atrophy, central hypothyroidism may be caused by inactivating mutations in several of the genes that code for the various proteins involved in the regulation of the hypothalamo-pituitary-thyroid axis (HPTA). These experiments of nature allow us to better understand the pathophysiology but also the normal physiology of the HPTA. This review will analyze reports of mutations that affect the HPTA and result in either isolated central hypothyroidism or in the syndrome of combined pituitary hormone deficiency (CPHD). Mutations have been identified in the genes for the TRH receptor, the transcription factors Pit-1 and PROP1, and the TSH beta-subunit.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10800768     DOI: 10.1007/BF03343692

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  68 in total

Review 1.  Anterior pituitary development: short tales from dwarf mice.

Authors:  J W Voss; M G Rosenfeld
Journal:  Cell       Date:  1992-08-21       Impact factor: 41.582

2.  Congenital central hypothyroidism due to a homozygous mutation in the thyrotropin beta-subunit gene follows an autosomal recessive inheritance.

Authors:  B M Doeker; R W Pfäffle; J Pohlenz; W Andler
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

3.  The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein.

Authors:  M Bodner; J L Castrillo; L E Theill; T Deerinck; M Ellisman; M Karin
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

4.  Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse.

Authors:  M P Wajnrajch; J M Gertner; M D Harbison; S C Chua; R L Leibel
Journal:  Nat Genet       Date:  1996-01       Impact factor: 38.330

5.  Monoallelic expression of normal mRNA in the PIT1 mutation heterozygotes with normal phenotype and biallelic expression in the abnormal phenotype.

Authors:  N Okamoto; Y Wada; S Ida; R Koga; K Ozono; H Chiyo; A Hayashi; K Tatsumi
Journal:  Hum Mol Genet       Date:  1994-09       Impact factor: 6.150

6.  Congenital isolated thyrotrophin releasing hormone deficiency.

Authors:  H Niimi; H Inomata; N Sasaki; H Nakajima
Journal:  Arch Dis Child       Date:  1982-11       Impact factor: 3.791

7.  Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone.

Authors:  P Beck-Peccoz; S Amr; M M Menezes-Ferreira; G Faglia; B D Weintraub
Journal:  N Engl J Med       Date:  1985-04-25       Impact factor: 91.245

8.  Pit-1/growth hormone factor 1 splice variant expression in the rhesus monkey pituitary gland and the rhesus and human placenta.

Authors:  J T Schanke; C M Conwell; M Durning; J M Fisher; T G Golos
Journal:  J Clin Endocrinol Metab       Date:  1997-03       Impact factor: 5.958

Review 9.  Hypothalamic thyrotropin-releasing hormone and thyrotropin biological activity.

Authors:  L Persani
Journal:  Thyroid       Date:  1998-10       Impact factor: 6.568

10.  A novel E250X mutation of the PIT1 gene in a patient with combined pituitary hormone deficiency.

Authors:  Y Irie; K Tatsumi; M Ogawa; T Kamijo; C Preeyasombat; C Suprasongsin; N Amino
Journal:  Endocr J       Date:  1995-06       Impact factor: 2.349

View more
  1 in total

1.  TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis.

Authors:  Johannes W Dietrich; Gabi Landgrafe; Elisavet H Fotiadou
Journal:  J Thyroid Res       Date:  2012-12-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.